Treatment with tofacitinib led to a lower risk for death or respiratory failure through day 28, compared with placebo, in patients hospitalized with COVID-19 pneumonia, according to data published in The New England Journal of Medicine. “Severe manifestations of SARS-CoV-2 infection are associated with an exaggerated immune response driven by interleukin-6, tumor necrosis factor , and other
Symptoms of depression among frontline COVID-19 nurses decreased after using a mindfulness app for 1 month, according to results published in Annals of the American…
Use of a palliative care screening tool within 24 hours of ICU admission vs. traditional consultative methods helped identify more patients in need of this…
Some antipsychotics other than olanzapine lowered the risk for hospitalization due to psychotic relapse among individuals with first-episode psychosis and co-occurring cannabis use disorder, according…
DENVER —Extracorporeal membrane oxygenation therapy led to favorable survival and neurologic outcomes for patients who required neurosurgical intervention, according to a poster at the American…
BOSTON — In this Healio Video Perspective from Eyecelerator@ASCRS, Matt Link, chief commercial officer of Sight Sciences, shares information on the company’s clinical trials.
In a large Danish cohort, heart failure was a more significant CV complication than stroke after diagnosis of atrial fibrillation, which became more common over…
Use of immune checkpoint inhibitors for pregnant women with cancer may be safer than previously thought, according to study results published in JAMA Network Open.Patients…
A 42-year-old man with no past medical history and prescribed no medications presented to the ED with complaints of pain and swelling in his left…
Bayer AG and its subsidiary Asklepios BioPharmaceutical announced the FDA granted fast track designation for its investigational gene therapy for the treatment of congestive heart…
PHILADELPHIA — Denosumab successfully induces structural modifications patients with active erosive hand osteoarthritis, according to data presented at ACR Convergence 2022.
